Clinical Trial Update: Bioequivalence Study of Chiglitazar/Metformin Extended-Release Tablets [NA]

View source ↗

Summary

A clinical trial update for a bioequivalence study of Chiglitazar combined with Metformin Extended-Release tablets in type 2 diabetes, currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Chiglitazar (Chiglitazar)
• Metformin Extended-Release Tablet (metformin extended-release)

Snippet

Sponsor: Chipscreen Biosciences, Ltd. | Conditions: T2DM (Type 2 Diabetes Mellitus) | NA | Status: NOT_YET_RECRUITING